| Rosuvastatin | Atorvastatin | ||||
---|---|---|---|---|---|---|
 | Western | Asian | p | Western | Asian | p |
N/arm | 869/2 | 304/3 | Â | 772/2 | 366/6 | Â |
Mean LDL-C at baseline (mg) | 124.2 ± 5.1 | 123.1 ± 14.6 | 0.928 | 129.8 ± 14.2 | 124.1 ± 12.7 | 0.610 |
Mean LDL-C at follow up (mg) | 61.9 ± 0.9 | 67.2 ± 13.8 | 0.642 | 73.1 ± 4.1 | 72.9 ± 14.2 | 0.986 |
LDL-C Mean reducing percentage | 49.9 ± 2.6 | 44.0 ± 4.8 | 0.221 | 43.0 ± 2.1 | 40.7 ± 5.5 | 0.600 |
Statin dosage (mg) | 40.0 ± 0.0 | 14.1 ± 4.9 | 0.006 | 80.0 ± 0.0 | 18.9 ± 2.9 | <0.001 |
Duration (month) | 24.0 ± 0.0 | 10.3 ± 3.7 | 0.016 | 22.0 ± 2.8 | 7.8 ± 2.2 | <0.001 |